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Abstract 
Objective: Venous thromboembolism (VTE) is major problem after hip fracture surgery with substantial morbidity 
and mortality. This study aimed to assess the postoperative compliance of thromboprophylaxis in elderly patients 
undergoing hip fracture surgery and to confirm the correlation between compliance and VTE risk.
Methods: This retrospective cohort study included consecutive elderly hip fracture patients who undergoing 
surgery. According to the thromboprophylaxis regimens, patients were divided into non-compliant group (<14days), 
poor compliant group (14–27days) and good compliant group (≥28days). The primary outcome was the incidence of 
symptomatic DVT, PE within 6weeks postoperatively.
Results: Between 2008 and 2012, 1214 eligible patients were included in this study. 761 (64.7%) patients were non-
compliant, 224 (19.0%) patients were poor compliant, and 192 (16.3%) patients were good compliant. The overall VTE 
rate was 7.9% (73/1177), PE rate was 0.3% (4/1177). The VTE rate in good compliant group was lowest among three 
groups (4.2 vs. 5.4 vs. 9.6%, P=0.013), but the PE rates showed no significant differences (0 vs. 0.9 vs. 0.3%, P=0.241). 
The multivariate analysis showed that non-compliance was an independent risk factor of suffering VTE undergoing 
hip fracture surgery.
Conclusions: In this study we found fewer than 1 in 5 patients maintained compliant with thromboprophylaxis 
guidelines after discharge following hip surgery. This is particularly concerning because those who were non-compli-
ant had a higher risk of VTE postoperatively compared with those who were good compliant.
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Background
Venous thromboembolism (VTE) is a leading cause of 
mortality among patients in hospital (Goldhaber 2012; 
Geerts et al. 2008). Major orthopedic surgery (include hip 
or knee replacement or hip fracture surgery) is associated 
with a high risk of VTE for a long time period (Ander-
son et  al. 2002; Prandoni et  al. 2002; Haentjens et  al. 
2004; Kolb et  al. 2003). Therefore, thromboprophylaxis 
has been recommended in several international guide-
lines (Members et al. 2012; Jacobs et al. 2012; Falck-Ytter 
et  al. 2012). In 2012, American College of Chest Physi-
cians guidelines on antithrombotic and thrombolytic 
therapy were published (ACCP9), and it was recom-
mended that anticoagulant should be used in patients 
undergoing hip fracture surgery for at least 10–14days 
postoperatively, but preferably for as much as 28–35days 
(Falck-Ytter et al. 2012). Several clinical studies and meta-
analyses have shown that extended chemoprophylaxis 
significantly reduces the incidence of symptomatic DVT 
in orthopedic surgery patients (Fisher et al. 2013; Kakkar 
et al. 2008; QuinlanDaniel et al. 2002).
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New oral anticoagulants are recommended, but 
LMWH are suggested as the preferred option for 
patients undergoing total hip arthroplasty (THA) or 
total knee arthroplasty (TKA) (Francis 2013). Some 
studies reported that new oral anticoagulants as rivar-
oxaban were safe and efficacy to reduce VTE rate in hip 
fracture patients (Long et  al. 2014; Turpie et  al. 2012). 
There is a clear trend toward shorter hospitalization 
of patients after major orthopedic surgery, leading to 
greater importance of outpatient thromboprophylaxis 
(Bergqvist et al. 2012). This means that the vast majority 
of patients may receive a daily pharmacological prophy-
laxis at home when discharge from hospital. However, 
the compliance may be a barrier of thromboprophy-
laxis, (Rahme et al. 2008) reported that fewer than 1 in 
5 elderly patients discharged home after a hip or knee 
replacement surgery received postdischarge thrombo-
prophylaxis. Few studies have assessed patient compli-
ance with thromboprophylaxis after hospital discharge 
suggesting that patients can learn to self-administer 
treatments and comply with thromboprophylactic regi-
mens (Colwell et al. 2005; Watts and Howie 2006; Mazor 
et al. 2007; Fisher and Turpie 2008; Spahn 2014). How-
ever, there is little information about the thrombopro-
phylactic compliance in the real world, especially in 
Chinese population. As insufficient community health 
services were provided in China (Anand et al. 2008), we 
were concerned that the thromboprophylactic compli-
ance would be poor. Thus the aim of this study was to 
assess the prevalence of thromboprophylaxis compliance 




We conducted a retrospective cohort study using admis-
sions, physician claims, drug claims, demographic 
records and diagnosis information obtained from the 
electronic medical records of the General Hospital of 
PLA between January 2008 and December 2012. Eligible 
patients were those aged 50years or older who had femur 
neck fractures or intertrochanteric fractures. Exclusion 
criteria included: pathological fractures; did not undergo 
surgery for various reasons; diagnosed with any type 
of VTE at admission or before surgery; be contraindi-
cated to pharmacological prophylaxis because of risk of 
bleeding. The study protocol was approved by the Ethic 
Committee of Chinese PLA General Hospital. Due to its 
retrospective nature and the fact that the patient data 
were anonymous, informed consent was not requested 
from patients.
Thromboprophylaxis regimens and definition 
of compliance
All the hip fracture patients received routine drug and 
or mechanical preventive measures according to current 
guidelines. The drugs were used from the evening of the 
day the patients were admitted to hospital to the evening 
of the day before surgery if the surgery were not emer-
gency. Subsequently, the regimen was resumed at least 8h 
after surgery and continued until discharge. The attend-
ing physicians would prescribe anticoagulants for every 
eligible patients and recommend a standard duration 
of 35days of chemoprophylaxis when discharged from 
hospital.
The pharmacological prophylaxis included unfraction-
ated heparin (UFH), LMWH (nadroparin), fondaparinux, 
danaparoid and rivaroxaban. The LMWH was the first 
choice of chemoprophylaxis and followed by rivaroxa-
ban and fondaparinux. Mechanical thromboprophylaxis 
was performed on all patients unless the patients refused 
to used it. The information of drugs used for thrombo-
prophylaxis were collected from the prescriptions of 
every patient and an outpatient interview or telephone 
interview.
We defined thromboprophylaxis compliance as any 
type of pharmacological prophylaxis extended to 28days 
postoperatively (good compliant group, GC). Partial 
compliance was defined as prophylaxis continuing to 
14–27days postoperatively (poor compliant group, PC), 
and non-compliance was defined as prophylaxis shorter 
than 14days or did not receive any pharmacological 
prophylaxis (non-compliant group, NC).
Outcome measures
After admission to hospital, laboratory investigations 
such as routine blood tests, biochemistry and coagula-
tion tests, were performed on every patients. And deep 
venous thrombosis was assessed by means of whole leg 
compression ultrasound (CUS) at admission. Whole leg 
CUS was repeated in patients who suffered from symp-
toms of suspected deep vein thrombosis (DVT) such as 
lower limb swelling, local tenderness and unexplained 
fever. A diagnosis of DVT was made based on the results 
of ultrasound. Lung ventilation/perfusion scanning or 
spiral CT was performed in patients with chest pain, 
breathing difficulties and other symptoms of suspected 
pulmonary embolism (PE). A diagnosis of PE was based 
on the results of the examinations. All patients returned 
to the clinic at 4, 8, 12weeks postoperatively and the 
would be recommended to received whole leg CUS 
examination if any symptoms of suspected DVT or PE 
were detected.
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Major bleeding events was defined as bleeding that 
was fatal, that involved a critical organ, or that required 
reoperation or clinically overt bleeding outside the sur-
gical site that was associated with a decrease in the 
hemoglobin level of 2g or more per deciliter or requir-
ing infusion of 2 or more units of blood. Minor bleeding 
events including hemorrhagic wound complications such 
as excessive wound hematoma or bleeding at the surgical 
site.
The primary outcome of this study was the incidence of 
symptomatic DVT, PE within 6weeks postoperatively as 
the standard duration of chemoprophylaxis was 5weeks 
after hip fracture surgery.
Statistical analysis
Student’s t test was used to analyze continuous data for 
comparisons of the baseline characteristics of the vari-
ous patients groups. Pearson’s Chi square test, Fisher’s 
exact test and analysis of variance (ANOVA) were used 
for inter-group or inner-group comparisons of constitu-
ent ratios. Logistic regression analysis was used for 2-cat-
egory data. Multivariate analysis was performed by the 
stepwise maximum likelihood method, and 95% confi-
dence intervals (CIs) and odds ratio (OR) values were 
used to describe the hazard ratio. A P value less than 0.05 
was considered statistically significant. All statistical pro-




In total, 1396 elderly patients admitted to our hospi-
tal suffering hip fracture during 2008 to 2012. Of these 
patients, 93 (6.7%) were diagnosed as deep vein throm-
bosis (DVT) at admission and been treated with antico-
agulants, 89 did not undergo surgery for various reasons 
(five patients died before operation). Then, 1214 patients 
were included in this study. There were 37 (3.1%) patients 
lost contact during 1months follow-up periods, so the 
remained 1177 patients were analyzed at last. All patients 
entered/enrolled in this study are accounted for in Fig.1.
On average, all the patients were aged 75.2 (standard 
deviation [SD] 10.2) years range from 50 to 109years old. 
Of these patients, 63.0% were female, 54.5% were femur 
neck fracture, 761 were classified to NC group, 224 were 
PC group, and 192 were GC group.
We compared the demographic characteristics 
between three groups and data was shown in Table1. 
There were no significant differences about the age, gen-
der, comorbidities among three groups. However, the 
proportion of femur neck fracture and patients received 
chemoprophylaxis before surgery was lower in NC group 
than others (P=0.001). The prevalence of mechanical 
thromboprophylaxis was highest and the coverage of 
medical insurance was lowest in GC group (P=0.001). 
Although all patients were prescribed any one of antico-
agulants after discharge in our hospital, but only 16.3% 
were completely compliant with physicians’ advices.
VTE incidence
Patients in NC group had a proportionally higher rate 
of DVT (9.6 vs. 5.4 vs. 4.2%, P=0.013) postoperatively, 
mainly driven by higher rates of distal DVT (7.1 vs. 4.0 
vs. 3.1%, P=0.048). No significant differences in rates 
for proximal DVT or PE were not found (Table 2). No 
fatal PE was found in this study. The DVT rates were 
not significant different during hospitalization prior to 
discharge (3.4 vs. 2.2 vs. 3.1%, P=0.671), however it was 
obviously higher in NC and PC group (6.2 vs. 3.1 vs. 
1.0%, P=0.005).
Patients all experienced low rates of major or minor 
bleeding events in three groups (Table 2), and it showed 
no significant difference (P=0.301, P=0.166 separately). 
No fatal bleeding events or bleeding into a critical site 
were found in this study, all patients experienced major 
bleeding events received effectively treatment.
Multivariate analysis
In multivariate analysis, the history of VTE, HRT, malig-
nant tumor and non compliance were confirmed to be 
independent risk factors of VTE after surgery of hip 
fracture (Table 3). The odds ratio (OR) of non-compliant 
compared with good compliant was 2.77 (95% confidence 
interval [CI], 1.27–6.04; P=0.010).
Discussion
We were not surprised about such a low rate of com-
pliance of thromboprophylaxis in China. We found an 
extremely low compliant rate in our hip fracture patients 
after surgery. There were only 16.6% hip fracture patients 
adhered to the doctors’ prescription after discharge. This 
finding is in line with published studies no matter which 
drugs been used (Rahme et al. 2008; Colwell et al. 2005; 
Watts and Howie 2006; Fisher and Turpie 2008; Spahn 
2014; Karlinski et  al. 2006). Adamali et  al. (2013) estab-
lished a national house-staff audit to assess the compli-
ance of thromboprophylaxis in medical patients and 
found the compliance rate was lower than 29.7%. This 
is unacceptable according to the ACCP guidelines and 
required to improve the compliance. If patients are non-
compliant after discharge, they may miss approximately 
40–50% of their entire thromboprophylaxis (Wilke et al. 
2010). The overwhelmed researches show that clinically 
relevant DVT and PE occur at a median of 20 and 21days 
after TKA and 12 and 34days after THA (Warwick et al. 
2007; Bjornara et  al. 2006). Therefor, non-compliance 
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may had detrimental resistance on the thromboprophy-
laxis efficiency.
We afterwards confirmed that the non-compliance 
was correlated with higher VTE rate. This situation is 
very depressed for both doctors and patients. Even when 
we adjusted with other risk factors of VTE, such as age, 
gender, fracture type, mechanical thromboprophylaxis 
and chemoprophylaxis before surgery, the compliance 
of thromboprophylaxis was independently associated 
with higher VTE incidence postoperatively. The extended 
duration of chemoprophylaxis is significantly more 
effective in preventing venous thromboembolism in 
Fig.1 Flowchart of included patients and data analysis in this study
Table1 The basic and demographic characteristics between three groups
VTE venous thromboembolism, fxs fractures, SD standard deviation
Non-compliant group Poor compliant group Good compliant group P value
N %/SD N %/SD N %/SD
Number 761 64.7 224 19.0 192 16.3 NA
Age 75.1 10.2 76.0 9.6 75.0 11.0 0.476
Gender (female) 476 62.5 146 65.2 119 62.0 0.738
Type of fxs (femur neck fracture) 378 49.7 141 62.9 122 63.5 0.001
History of VTE 13 1.7 4 1.8 3 1.6 0.984
Hormone replacement therapy 2 0.3 1 0.4 3 1.6 0.147
Diabetes 155 20.4 47 21.0 44 22.9 0.740
Hypertension 347 45.6 111 49.6 89 46.4 0.580
Ischemic heart disease 136 17.9 46 20.5 34 17.7 0.643
Cerebrovascular disease 113 14.8 40 17.9 30 15.6 0.551
Malignant tumor 33 4.3 11 4.9 10 5.2 0.847
Mechanical thromboprophylaxis 91 12.0 37 16.5 54 28.1 0.001
Chemophrophylaxia before surgery 532 69.9 179 79.9 165 85.9 0.001
Medical insurance 463 60.8 147 65.6 64 33.3 0.001
Page 5 of 7Gao et al. SpringerPlus  (2016) 5:1362 
orthopedic surgery patients than the recommended 
practice of at least 10days. Our results demonstrated 
that extended duration of more than 4weeks was signifi-
cantly more effective than less than 2weeks. The com-
pliance of thromboprophylaxis after discharge was the 
key stone of preventing venous thromboembolism. We 
should noticed that, although the VTE rate was signifi-
cantly higher in GC group than NC group, it was not sig-
nificant different between GC group and PC group. The 
multivariate analysis confirmed that non-compliant was 
an independent risk factor for VTE (OR 2.77, 95% CI 
1.27–6.04), however, the poor compliant was not inde-
pendent (OR 1.41, 95% CI 0.55–3.63). This means that we 
should ensure 2weeks of chemoprophylaxis at least after 
hip fracture surgery to preventing venous thromboembo-
lism effectively.
Although more patients in GC group received chem-
oprophylaxis before surgery, it could not affect the 
postoperative VTE rate as the patients diagnosed VTE 
were excluded from this study. And the multivariate 
analysis confirmed its influence was limited. Consid-
ering the different proportion of mechanical throm-
boprophylaxis in different groups, we compared the 
VTE rate during hospitalization prior to discharge. 
The results revealed that no significant differences 
were detected during this period, when the mechanical 
devices were applied.
In our study, we were able to show the existence of high 
rate of non-compliance in hip fracture patients after dis-
charge. Reasons for this were very complex. Objectively, 
the lack of primary healthcare institutions and deficiency 
of home nursing in China were main causes of non-com-
pliance (Gong 2012). The drug-related problems may 
be main reason for such a high non-compliance rate in 
Table2 VTE rates and bleeding events in all three groups
VTE venous thromboembolism, DVT deep venous thrombosis, PE pulmonary embolism, SD standard deviation
Non-compliant group Poor compliant group Good compliant group P value
N % N % N %
Number 761 224 192 NA
PE in 1month 2 0.3 2 0.9 0 0.0 0.241
DVT in 1month 73 9.6 12 5.4 8 4.2 0.013
Proximal DVT 19 2.5 3 1.3 2 1.0 0.282
Distal DVT 54 7.1 9 4.0 6 3.1 0.048
VTE in hospital 26 3.4 5 2.2 6 3.1 0.671
VTE after discharge 47 6.2 7 3.1 2 1.0 0.005
VTE in total 73 9.6 12 5.4 8 4.2 0.001
Major bleeding events 4 0.5 3 1.3 1 0.5 0.474
Minor bleeding events 16 2.1 10 4.5 6 3.1 0.150
Table3 Univariate and multivariate analysis using logistic 
regression models to  evaluate the potential risk factors 
for the occurrence of VTE in hip fracture patients
VTE venous thromboembolism, fxs fractures, SD standard deviation, OR odds 
ratio, CI confidence interval
P value OR 95 % lower CI 95 % higher CI
Univariate analysis
Age 0.851 1.002 0.981 1.023
Gender (female) 0.920 1.023 0.659 1.588
Type of fxs (femur 
neck fracture)
0.314 0.804 0.527 1.229
History of VTE 0.001 5.271 1.976 14.058
Hormone replace-
ment therapy
0.003 12.011 2.390 60.372
Diabetes 0.518 0.835 0.484 1.441
Hypertension 0.486 0.859 0.560 1.317
Ischemic heart 
disease
0.258 0.705 0.385 1.292
Cerebrovascular 
disease
0.293 1.34 0.78 2.30
Malignant tumor 0.851 1.002 0.981 1.023
Mechanical throm-
boprophylaxis
0.629 1.149 0.654 2.018
Chemophrophylaxia 
before surgery
0.763 0.93 0.58 1.50
Medical insurance 0.211 1.32 0.85 2.05
Poor compliant 0.572 1.302 0.521 3.254
Non-compliant 0.019 2.440 1.155 5.155
Multivariate analysis
History of VTE 0.001 5.58 2.05 15.21
Hormone replace-
ment therapy
0.002 15.28 2.64 88.35
Malignant tumor 0.048 2.24 1.01 4.97
Poor compliant 0.476 1.41 0.55 3.63
Non-compliant 0.010 2.77 1.27 6.04
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this study as we do not have a comprehensive network of 
inpatients rehabilitation clinics in China. This enforced 
our patients to inject anticoagulants at their home and 
this is very hard to apply. Additionally, insurance was 
another factor influencing the compliance of patients. 
Insurance coverage may influenced the compliance after 
discharge because the new oral anticoagulants were not 
covered by medical insurance right now. We observed 
that self-paying patients complied with doctors’ advices 
and preferred to pay for the anticoagulants. So the pro-
portion of insurance was rather low in compliance group. 
Subjectively, the health literacy of Chinese adults should 
be improved as the poor public understanding of impor-
tance of thromboprophylaxis may be great barriers. And 
also the communication between doctors and patients 
usually was insufficient in our country.
Our results suggested an urgent improvement on the 
thromboprophylaxis compliance after hip fracture sur-
gery. The patients’ education regarding thrombosis risk 
may be effective to improve the compliance (Mazor et al. 
2007). The SALTO study found that adherence to and sat-
isfaction with the oral thromboprophylaxis were better 
than for drop by injection in the context of outpatient’s 
prolongation (Peidro-Garces et al. 2013). Several studies 
demonstrated that the prescription of rivaroxaban could 
afford a superior patient compliance compared with sub-
cutaneous LMWH or enoxaparin (Carrothers et al. 2014; 
Rubenacker et al. 2013; Rogers et al. 2010). And Wilke’s 
survey revealed the patients appeared to have a posi-
tive preference for oral thromboprophylaxis after major 
orthopedic surgery (Wilke 2009).
Limitations
There were some limitations in our study. Firstly, due to 
the retrospective design, recall bias was unavoidable and 
we did not contain the medical history of warfarin, aspi-
rin and NSAIDs. For example, patients may have misre-
membered the anticoagulant they used and duration of 
prophylaxis. The diagnosis of VTE was based on patient’s 
symptoms and physician’s judgment, thus may under-
estimated the VTE rate. Additionally, the definition of 
compliance was established on the extension to 35days 
thromboprophylaxis as recommended by ACCP9 guide-
line. However, we could not treat all patients as same 
situation because some patients were received individual 
advices by their doctors.
Conclusions
In this study we found fewer than 1 in 5 patients main-
tained compliance in thromboprophylaxis after dis-
charge following hip surgery despite clinical guidelines. 
This is particularly concerning because those who were 
non-compliance had higher risk of VTE within 3months 
postoperatively compared with those who were partial or 
completely compliance in thromboprophylaxis.
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